The newly launched devices are next-gen expandable implants designed to provide an optimal fit for patients to restore sagittal balance and enhance structural fixation, the Audobon, Penn.-based company said.
“Elsa AL is the alternative to Rise-L for selected cases in which maximizing segmental lordosis is indicated. In conjunction with the ALL release technique, Elsa AL has the potential to provide the most amount of segmental lordosis of any device on the market,” Dr. Paul Kim of the Carolina Neurosurgery & Spine Associates said in a press release.
Globus Medical said the Elsa AL’s in situ adjustability and integrated screw fixation are intended to help correct sagittal balance and improve stability, and added that it features adjustable lordotic technology to allow 30 degrees of lordosis with a minimally invasive surgical corridor.
The company touted the Elsa-ATP as the only expandable spacer designed to avoid nerve complications through the use of an anterior-to-psoas approach.
“Our product development team’s continued commitment to innovation has enabled us to design expandable interbody technology for nearly every surgical approach. The addition of these two unique Elsa spacers to our expandable lateral portfolio demonstrates our commitment to listening and responding to our customers’ needs through continuous product innovation. The use of an expandable spacer for the ATP approach may help reduce complications associated with the lateral procedure. With restoration of alignment being of critical importance, these implants were developed as a tool to help surgeons address sagittal imbalance, with the goal of maximizing lordotic correction,” Globus global product dev senior VP Andrew Iott said in a prepared statement.